SEKISUI Diagnostics, a global medical diagnostics manufacturer, has announced the launch of a 510(k) cleared rapid test to detect COVID-19 and Flu A&B in professional healthcare settings.
ASX companies are targeting a growing point-of-care testing market, which is set to reach US$85.55 billion by 2033. ... Read ...